In focus
Latest feed
Vertex Pharmaceuticals Makes a Major Play, Acquiring Crinetics in a Near-$5 Billion Deal
Biotech Power Play: Vertex's Bold Leap into Endocrine Therapies
Vertex's Bold $10 Billion Bet: Reshaping the Biotech Landscape
Pfizer Shares Slip After Seagen’s Origin Cancer Drug Delivers Mixed Top‑line Results
